Skip to main content
. 2011 Oct 7;17(37):4206–4212. doi: 10.3748/wjg.v17.i37.4206

Table 3.

Follow-up data for patients who underwent orthotopic liver transplantation for hepatocellular carcinoma n (%)

Variables Milan + Milan -/UCSF + UCSF -
No. of patients 34 7 15
Post-operative death 2 (5.9) - 1 (4.5)
Death 5 (14.7) 2 (28.6) 11 (73.3)
HCC recurrence 2 (5.8) 1 (14.3) 6 (40.0)
Median follow-up 51.5 (1:124) 32 (1:66) 14 (3:66)

UCSF: University of California San Francisco; HCC: Hepatocellular carcinoma.